SUPPLEMENT TO THE PROXY STATEMENT
FOR THE 2019 ANNUAL MEETING OF SHAREHOLDERS
TO BE HELD ON APRIL 30, 2019
The following information supplements the
proxy statement (the “Proxy Statement”) of The Chemours Company (“Chemours” or the “Company”)
furnished to shareholders of the Company in connection with the solicitation of proxies by the Board of Directors (the “Board”)
for the 2019 Annual Meeting of Shareholders (the “2019 Annual Meeting”) to be held on April 30, 2019 in the Caesar
Rodney Ballroom at The Westin Hotel, located at 818 Shipyard Drive, Wilmington, DE 19801, at 10:00 a.m. (Eastern time). Capitalized
terms used in this supplement to the Proxy Statement (this “Supplement”) and not otherwise defined in this Supplement
have the meaning given to them in the Proxy Statement. This Supplement is being filed with the Securities and Exchange Commission
and being made available to shareholders on April 16, 2019.
The information set forth in
this Supplement is in addition to the information set forth in the Proxy Statement, and should be read in conjunction with
the Proxy Statement.
The purpose of this Supplement is to reiterate
the Board’s recommendation of a vote “FOR” the election of each of its eight director nominees, and to provide
additional information about the Company’s proposal (the “2018 Proposal”) at the 2018 Annual Meeting of Shareholders
(the “2018 Annual Meeting”) to eliminate provisions in the Company’s Amended and Restated Certificate of Incorporation
(the “Certificate”) that require a supermajority vote of shareholders in order for the Company to amend certain provisions
of the Certificate and all provisions of the Company’s Amended and Restated Bylaws. In addition, this Supplement provides
additional information about the Company’s shareholder engagement efforts on the 2018 Proposal since the 2018 Annual Meeting,
and the determination of the Nominating and Corporate Governance Committee not to recommend resubmission of the 2018 Proposal at
the 2019 Annual Meeting.
The supermajority voting provisions that
were the subject of the 2018 Proposal were put in place by E.I. du Pont de Nemours and Company (“DuPont”) prior to
Chemours’ spin-off from DuPont in July 2015, when Chemours was a wholly-owned subsidiary of DuPont. The Company’s
Board, as presently constituted, did not vote upon or adopt these provisions.
Since the spin-off, the Board has
engaged in ongoing review of the Company’s corporate governance principles. The Nominating and Corporate Governance
Committee has led this review, and as a result of its recommendations the Company has substantially enhanced its corporate
governance principles since the spin-off. At the 2016 Annual Meeting of Shareholders, its first as an independent company,
Chemours obtained the approval of its shareholders to declassify the Board so that all directors are elected on an annual
basis. Uncontested director elections are subject to a majority voting standard. Chemours has an independent Chairman of the
Board, and all members of the Board, other than the President and CEO, are independent. Chemours has also adopted claw-back
and anti-hedging policies as well as robust stock ownership guidelines.
As a continuation of this effort to review
and seek enhancements of Chemours’ corporate governance profile, upon recommendation of the Nominating and Corporate Governance
Committee, the 2018 Proposal was submitted by the Board to the Company’s shareholders at the 2018 Annual Meeting. The voting
standard required to approve the 2018 Proposal was at least eighty percent (80%) of the voting power of the Company’s stock
then outstanding, with abstentions and broker non-votes having the same effect as votes “against” the 2018 Proposal.
The Board recognized the difficulty of meeting this high voting standard, which, as noted above, was put in place prior to the
spin-off. The Board therefore directed the Company to engage an outside proxy solicitor, Innisfree M&A Incorporated, to assist
in the solicitation efforts.
Despite the Company’s efforts
and the time and expense associated with this solicitation effort, the vote on the 2018 Proposal fell significantly short
of the required threshold, receiving the support of 73.8% of the outstanding shares.
Significantly, had one hundred percent
(100%) of the shares voting at the 2018 Annual Meeting voted to approve the 2018 Proposal, the vote on that proposal still would
have fallen more than 11 million shares short of the required approval threshold.
In view of these results, the Nominating
and Corporate Governance Committee recommended to the Board that the supermajority provisions continue to be studied, and that
the Company take careful note of any views expressed by the shareholders of the Company in the Company’s regular shareholder
engagement process following the 2018 Annual Meeting. During the course of this engagement process, no shareholder raised any concerns
about the supermajority provisions or suggested the 2018 Proposal should be submitted to the shareholders for approval again.
The Nominating and Corporate Governance
Committee and the Board believe that their fiduciary duties require them to carefully consider expenses and allocation of time
and senior management resources in the context of governance decisions. Because no shareholders raised concerns about the 2018
Proposal and based on the informed view that obtaining approval of the 2018 Proposal, if resubmitted, would be highly challenging,
if not impossible, the Nominating and Corporate Governance Committee and the Board determined that it was not in the best interests
of shareholders to incur costs and resource usage associated with resubmitting the 2018 Proposal at the 2019 Annual Meeting of
Shareholders.
Under the direction of the Nominating
and Corporate Governance Committee, the Company will continue its regular program of engagement with shareholders. If
shareholders express a significant desire to revisit the supermajority voting provisions, the Nominating and Corporate
Governance Committee would expect to recommend that the Board resubmit the 2018 Proposal to the shareholders for approval at
the 2020 Annual Meeting of Shareholders.
The Board of Directors recommends a vote
“FOR” the election of each of the director nominees named in the Proxy Statement.
Your
Vote is Important
Whether
or not you plan to attend the meeting, please vote by completing, signing and dating the proxy card that was included with the
Proxy Statement and promptly mailing it in the envelope provided or vote via the Internet or by telephone pursuant to the instructions
provided on the proxy card that was included with the Proxy Statement. If you have any questions or need assistance in voting your
shares, please call our proxy solicitor:
INNISFREE
M&A INCORPORATED
Shareholders
May Call Toll-Free: (888) 750-5834
Banks
and Brokers May Call Collect: (212) 750-5834